These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25681288)

  • 1. Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.
    Cui M; Au JL; Wientjes MG; O'Donnell MA; Loughlin KR; Lu Z
    J Urol; 2015 Jul; 194(1):230-7. PubMed ID: 25681288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
    Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
    J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.
    Verma A; Degrado J; Hittelman AB; Wheeler MA; Kaimakliotis HZ; Weiss RM
    BJU Int; 2011 Apr; 107(7):1154-61. PubMed ID: 20735383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.
    Wang J; Lu Z; Yeung BZ; Wientjes MG; Cole DJ; Au JL
    J Control Release; 2014 Mar; 178():79-85. PubMed ID: 24462901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
    Singh RP; Tyagi A; Sharma G; Mohan S; Agarwal R
    Clin Cancer Res; 2008 Jan; 14(1):300-8. PubMed ID: 18172282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
    Bae YJ; Yoon YI; Yoon TJ; Lee HJ
    Korean J Radiol; 2016; 17(4):497-508. PubMed ID: 27390541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
    Hou JQ; He J; Wang XL; Wen DG; Chen ZX
    Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment and application of an orthotopic murine bladder cancer model].
    Yang SM; Wen DG; Hou JQ; He J; Cen JN; Chen JH
    Ai Zheng; 2007 Apr; 26(4):341-5. PubMed ID: 17430648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
    Sun HB; Zheng HY; Yan X
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma growth inhibition in vitro and in vivo by single chain variable fragments of the transferrin receptor conjugated to survivin small interfering RNA.
    Wang F; Bai HR; Wang J; Bai YZ; Dou CW
    J Int Med Res; 2011; 39(5):1701-12. PubMed ID: 22117970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome.
    Hausladen DA; Wheeler MA; Altieri DC; Colberg JW; Weiss RM
    J Urol; 2003 Jul; 170(1):230-4. PubMed ID: 12796695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.
    Yang W; Sun T; Cao J; Liu F
    Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
    Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
    Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.
    Morikawa Y; Koike H; Sekine Y; Matsui H; Shibata Y; Ito K; Suzuki K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):584-9. PubMed ID: 22387542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SiRNA-mediated survivin inhibition enhances chemo- or radiosensivity of colorectal cancer cells in tumor-bearing nude mice.
    Chu X; Chen L; Wang J; Guan X; Geng H; Zhang Q; Song H
    Hepatogastroenterology; 2010; 57(104):1445-52. PubMed ID: 21443101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells.
    Dong H; Yao L; Bi W; Wang F; Song W; Lv Y
    J Cancer Res Ther; 2015; 11(4):717-22. PubMed ID: 26881507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.
    Zhang J; Ramesh N; Chen Y; Li Y; Dilley J; Working P; Yu DC
    Cancer Res; 2002 Jul; 62(13):3743-50. PubMed ID: 12097284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma.
    Song X; Wang JB; Yin DL; Yang HY; Liu LX; Jiang HC
    Chin Med J (Engl); 2009 Nov; 122(21):2636-42. PubMed ID: 19951584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
    Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
    Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.